ScreenerHero

CPHI China Pharma Holdings, Inc.

AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic · chinapharmaholdings.com
0.6411USD-1.82%Mkt Cap: 27.58M $P/E: —

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injecta…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$65.69BUSDP/E 25.5
TAK
Takeda Pharmaceutical Company Limited
$57.82BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.64BUSDP/E 65.2
HLN
Haleon plc
$39.01BUSDP/E 18.1
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.7
UTHR
United Therapeutics Corporation
$23.23BUSDP/E 19.4
VTRS
Viatris Inc.
$20.15BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.27BUSDP/E 111.6
NBIX
Neurocrine Biosciences, Inc.
$14.79BUSDP/E 21.3
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated
$11.23BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.40BUSDP/E 28.4
KRK
Krka, d. d.
$8.63BUSDP/E 19.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.07BUSDP/E 41.4
ALKS
Alkermes plc
$6.99BUSDP/E 109.6
HIMS
Hims & Hers Health, Inc.
$6.88BUSD
LNTH
Lantheus Holdings, Inc.
$6.53BUSDP/E 24.2
KNSA
Kiniksa Pharmaceuticals International, plc
$5.93BUSDP/E 77.9
APTX
Apotex Health Corp.
$5.27BUSD

Key Statistics

Company
Market Cap27.58M USD
Enterprise Value31.33M USD
Revenue (TTM)3.91M USD
Gross Profit-131.95K USD
Net Income (TTM)-3.19M USD
Revenue/Share0.20 USD
Last Price0.6411 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees215
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.16
EV/EBITDA-21.75
EV/Revenue8.01
P/S7.05
P/B0.72
EPS (TTM)-0.42
EPS (Forward)—
52W Range
0.38001% of range19.19
52W High19.19 USD
52W Low0.3800 USD
Profitability
Gross Margin-3.18%
Oper. Margin-150.98%
EBITDA Margin-36.81%
Profit Margin-76.91%
ROE-14.02%
ROA-10.28%
Growth
Revenue Growth-7.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF148.26K USD
CapEx (TTM)137.25K USD
FCF Margin28.26%
FCF Yield4.01%
Net Debt3.75M USD
Net Debt/EBITDA-2.60
Balance Sheet
Debt/Equity0.17
Current Ratio0.26
Quick Ratio0.07
Book Value/Sh0.89 USD
Cash/Share0.0070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 15, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.43.02M
Float3.30M
Insiders89.63%
Institutions0.47%
Short Interest
Short Ratio0.9d
Short % Float0.60%
Short % Out.0.42%
Shares Short182.61K
Short (prev mo.)623.76K
Technical
SMA 500.9104 (-29.6%)
SMA 2000.8818 (-27.3%)
Beta1.05
S&P 52W Chg16.45%
Avg Vol (30d)783.30K
Avg Vol (10d)367.94K
Technical Indicators
RSI (14)41.6
MACD-0.1215
MACD Signal-0.1256
MACD Hist.+0.0041
BB Upper0.9816 USD
BB Middle0.7595 USD
BB Lower0.5375 USD
BB Width58.47%
ATR (14)0.1790 USD
Vol Ratio (20d)0.41x